Chemical Name: 2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde compound with (8S,9R,10S,11S,13S,14S,16R,17S)-17-(2,2-dihydroxyacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (1:1)
Identification, characterization of degradation component in desoximetasone pharmaceutical dosage forms and its quantification in the presence of process related impurities
P. Srinivasu, K. Sudhakarbabu, and J. Sreeramulu.
Journal of Liquid Chromatography & Related Technologies, 35:1114–1129, 2012.
Development and Validation of RP-HPLC Method for Desoximetasone in Bulk and Cream Formulation
Ashish Gorle, Jayashri Mahajan, Prathamesh Bhave.
Journal of Drug Delivery & Therapeutics. 2019; 9(3):154-159.